Can a smartphone app lift depression in cancer survivors?

NCT ID NCT06930729

Recruiting now Symptom relief Sponsor: Medical University of South Carolina Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 15, 2026 · Updated 2 times

Summary

This study compares two ways to treat depression in cancer survivors: a mobile app called Moodivate that tracks activities and mood, and 8 sessions of telehealth therapy with a mental health provider. About 45 adults who have had cancer and currently feel depressed will take part. The goal is to see if a stepped-care approach—starting with the app and adding therapy if needed—is practical and helpful for improving emotional well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Behavioral Activation Therapy (via Moodivate app or telehealth)
What this could lead to: If successful, this could provide flexible, accessible depression care options tailored to cancer survivors.
What could go wrong: This is a small feasibility study, so results may not apply broadly. Risks include frustration, worsening distress, or data privacy concerns.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Depression depressive disorder neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER DEPRESSION

Contacts and locations

Locations

Medical University of South Carolina
RECRUITING

Charleston, South Carolina, 29425, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.